Patents by Inventor Michael John Alberti

Michael John Alberti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Avionic exhaust air for cooling engine bay
    Patent number: 11939076
    Abstract: An aircraft includes an airframe defining a first enclosed space, an engine bay disposed within the first enclosed space, and a cooling system. The engine bay includes a firebox defining a second enclosed space and an engine disposed at least partially within the second enclosed space. The cooling system is configured to selectively fluidly couple the first enclosed space with the second enclosed space.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: March 26, 2024
    Assignee: LOCKHEED MARTIN CORPORATION
    Inventors: Giuseppe S. Alberti, Adriano Cirioli, Sean Thomas Barrows, Nolan John Birtwell, Michael Alexander, Nicholas Scott Coury
  • Benzodiazepine derivatives that inhibit rock
    Patent number: 7888503
    Abstract: The present invention relates to dihydrobenzodiazepine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such dihydrobenzodiazepine derivatives are useful in the treatment of diseases associated with inappropriate ROCK kinase.
    Type: Grant
    Filed: October 18, 2005
    Date of Patent: February 15, 2011
    Assignee: GlaxoSmithKline LLC
    Inventors: Michael John Alberti, David Kendall Jung
  • Aminopyrazine derivatives and compositions
    Patent number: 7598251
    Abstract: The present invention relates to aminopyrazine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such aminopyrazine derivatives are useful in the treatment of diseases associated with inappropriate tyrosine and/or serine/threonine kinase activity.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: October 6, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Michael John Alberti, David Harold Drewry, David Drysdale Miller, Paul Bamborough
  • CHEMICAL COMPOUNDS
    Publication number: 20090143366
    Abstract: The present invention relates to dihydrobenzodiazepine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such dihydrobenzodiazepine derivatives are useful in the treatment of diseases associated with inappropriate ROCK kinase.
    Type: Application
    Filed: October 18, 2005
    Publication date: June 4, 2009
    Inventors: Michael John Alberti, David Kendall Jung
  • AMINOPYRAZINE DERIVATIVES AND COMPOSITIONS
    Publication number: 20090062307
    Abstract: The present invention relates to aminopyrazine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such aminopyrazine derivatives are useful in the treatment of diseases associated with inappropriate tyrosine and/or serine/threonine kinase activity.
    Type: Application
    Filed: October 31, 2008
    Publication date: March 5, 2009
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Michael John Alberti, David Harold Drewry, David Drysdale Miller, Paul Bamborough
  • PYRIDOPYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USES AS ANTI-CANCER AND ANTI-DIABETE DRUGS
    Publication number: 20090054471
    Abstract: The present invention relates to pyridopyrazolopyrimidine derivatives that are useful pharmacological agents through the inhibition or antagonism of protein kinases, and to processes for the preparation and use of the same. In particular, the present invention relates to compounds that demonstrate protein tyrosine kinase and/or protein serine/threonine kinase inhibition.
    Type: Application
    Filed: February 9, 2006
    Publication date: February 26, 2009
    Inventors: David Kendall Jung, Michael John Alberti
  • Aminopyrazine derivatives and compositions
    Patent number: 7459454
    Abstract: The present invention relates to aminopyrazine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medcicaments. Such aminopyrazine derivatives are useful in the treatment of diseases associated with inappropriate tyrosine and/or serine/threonine kinase activity.
    Type: Grant
    Filed: March 18, 2004
    Date of Patent: December 2, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: Michael John Alberti, David Harold Drewry, David Drysdale Miller, Paul Bamborough
  • Fused pyrazole derivatives being protein kinase inhibitors
    Patent number: 7166597
    Abstract: Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, R2, and R4 are various substituent groups, are protein kinase inhibitors
    Type: Grant
    Filed: August 22, 2001
    Date of Patent: January 23, 2007
    Assignee: Glaxo Group Limited
    Inventors: Michael John Alberti, Ian Robert Baldwin, Mui Cheung, Stuart Cockerill, Stephen Flack, Philip Anthony Harris, David Kendall Jung, Gregory Peckham, Michael Robert Peel, Jennifer Gabriel Badiang, Kirk Stevens, James Marvin Veal
  • Pyrazolopyridines, process for their preparation and use as therapeutic compounds
    Patent number: 7109209
    Abstract: The present invention provides compounds of formula (I): wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
    Type: Grant
    Filed: October 7, 2005
    Date of Patent: September 19, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Michael John Alberti, Stanley D. Chamberlain, Mui Cheung, Kristjan Gudmundsson, Philip Anthony Harris, Brian A. Johns, David Kendall Jung, Michael Robert Peel, Jennifer Badiang Stanford
  • Pyralopyridines, process for their preparation and use as therapeutic compounds
    Patent number: 7034030
    Abstract: The present invention provides compounds of formula (I): wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
    Type: Grant
    Filed: March 20, 2002
    Date of Patent: April 25, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Michael John Alberti, Stanley D. Chamberlain, Mui Cheung, Kristjan Gudmundsson, Philip Anthony Harris, Brian A. Johns, David Kendall Jung, Michael Robert Peel, Jennifer Badiang Stanford
  • Fused pyrazole derivatives bieng protein kinase inhibitors
    Publication number: 20040053942
    Abstract: Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, (R2, and R4 are various substituent groups, are protein kinase inhibitors.
    Type: Application
    Filed: July 7, 2003
    Publication date: March 18, 2004
    Inventors: Michael John Alberti, Ian Baldwin, Mui Cheung, Stuart Cockerill, Philip Harris, David Jung, Gregory Peckham, Michael Peel, Jennifer Badiang, Kirk Stevens, James Veal